113981-43-4

Basic information

• Product Name: Phenol, 2,6-dibromo-4-methyl-, sodium salt
• CAS NO: 113981-43-4
• Molecular Formula: C7H6Br2O.Na
• Molecular Weight: 287.914
• Mol File: 113981-43-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Phenol, 2,6-dibromo-4-methyl-, sodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2,6-dibromo-4-methyl-, sodium salt(113981-43-4)
• EPA Substance Registry System: Phenol, 2,6-dibromo-4-methyl-, sodium salt(113981-43-4)

Safety Data

• Hazardous Substances Data: 113981-43-4(Hazardous Substances Data)

Upstream product

• 2432-14-6 3,5-dibromo-4-hydroxytoluene 
• 106-44-5 p-cresol 
• 7646-69-7 sodium hydride 

Downstream Products

• 918945-88-7 3,5-dibromo-4-(4-nitro-phenoxy)-benzoic acid 
• 918945-85-4 methyl N-[4-(4-aminophenoxy)-3,5-dibromobenzoyl]glycinate 
• 918945-89-8 methyl N-[4-(4-nitrophenoxy)-3,5-dibromobenzoyl]glycinate 
• 957828-70-5 3,5-dibromo-4-(4-nitro-phenoxy)-benzoic acid methyl ester 
• 957828-48-7 4-(4-amino-phenoxy)-3,5-dibromo-benzoic acid methyl ester 
• 113965-60-9 1-(2,6-dibromo-4-methylphenoxy)-4-nitrobenzene 

Relevant articles and documents

NOVEL PHARMACEUTICAL COMPOSITIONS

The invention provides the use of compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, for the manufacture of a medicament for the treatment or prophylaxis of a condition that may be treated with a thyroid receptor agonist or partial agonist wherein R1, R2, R3, R4, Y, W and R5 are as defined in the specification. The invention also provides compounds of formula (Ia) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, formula (Ia) wherein R1, R2, R3, R4, Y, W and R5 are as defined in the specification.

HETEROCYCLIC COMPOUNDS AS AGONISTS FOR THE THYROID RECEPTOR

The invention provides Compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, wherein R3, R4, G, Y, W and R5 are as defined in the specification. The invention also provides the use of such Compounds in the treatment or Prophylaxis of a condition associated with a disease or disorder associated with thyroid receptor activity.

Soil fungicidal phosphorothioate

Novel phosphorothioates represented by the formula, STR1 wherein R1 is a chlorine or bromine atom, R2 is methyl or ethyl group and R3 is a chlorine or bromine atom or nitro group, which have a low toxicity to men and beasts as well as fishes, no phytotoxicity to crops, excellent fungicidal effect on injurious epidemic soil fungi in agriculture, horticulture and the like, and a wide range of uses for prevention of soil epidemics to effect the growth promotion of crops.